Adenovirus-mediated gene therapy
US6579855B1 · kind B1 · utility
3Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2001 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Jun 25, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An adenovirus having a functional thymidine kinase gene is useful in the treatment of brain tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.